Office of Research & Development |
![]() ![]() |
Project Number: | I01BX004621-01A1 |
Title: | Protein kinase C in Lung Cancer with mutant EGFR |
Principal Investigator: | Yusuf Hannun |
Location: | Northport, NY |
Congressional District Code: | 3 |
Research Service: | Biomedical Laboratory R&D |
Project Period: | April 2020 - March 2024 |
FY 2021 Funding Amount: | $156,800 |
Total Award Amount (all years): |
$710,000 |
Abstract: |
View full abstract and other project information on NIH RePORTER Go To NIH RePORTER Excerpt: Mutant EGFR (mEGFR) is a key driver of a subset of lung adenocarcinoma that is targetable by specific inhibitors; however, responses are transient, and patients almost always relapse, thus necessitating a deep understanding of the mechanisms involved in the action of mEGFR. Our studies are leading to the discovery of rewiring of EGFR signaling in mEGFR with a pivotal role played by protein kinase C (PKC). We find that patients with tumors having mEGFR often show a selection for very high levels... |